Call : (201) 343-5202
Nephros Reports Third Quarter Financial Results Product Revenue up 85% over Q3 2018 Reiterates Full-Year Revenue Guidance of $9.5-10 Million SOUTH ORANGE, NJ, November 6, 2019 – Nephros, Inc. (Nasdaq:NEPH),…
Download PDF »Nephros Announces Third Quarter 2019 Financial Results Conference Call SOUTH ORANGE, NJ, October 31, 2019 – Nephros, Inc. (Nasdaq: NEPH), a commercial stage company that develops and sells high performance…
Download PDF »Ringing The Nasdaq Stock Market Closing Bell Nephros, Inc. (Nasdaq: NEPH), a commercial stage company that develops and sells high performance water purification products to the medical device and commercial…
Download PDF »Nephros Announces Preliminary Financial Results for Third Quarter 2019 Anticipates $3.1 Million Product Revenue, 85% Growth Over 2018; Increases Full-Year Revenue Guidance to $9.5-10 Million SOUTH ORANGE, NJ, October 7,…
Download PDF »SOUTH ORANGE, NJ, September 3, 2019 – Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products to the medical device and commercial markets,…
Download PDF »
SOUTH ORANGE, NJ, August 13, 2019 – Nephros, Inc. (OTCQB: NEPH), a commercial-stage company that develops and sells high performance…
Download PDF »SOUTH ORANGE, NJ, August 7, 2019 – Nephros, Inc. (OTCQB:NEPH), a commercial stage company that develops and sells high performance water purification products to the medical device and commercial markets,…
Download PDF »SOUTH ORANGE, NJ, July 30, 2019 – Nephros, Inc. (OTCQB: NEPH), a commercial-stage company that develops and sells high performance water purification products to the medical device and commercial markets,…
Download PDF »Common Stock Will Trade Under Ticker “NEPHD” For 20 Trading Days SOUTH ORANGE, NJ, July 10, 2019 – Nephros, Inc. (OTCQB: NEPHD), a commercial-stage company that develops and sells high…
Download PDF »Anticipates $2.3 Million Net Revenue; 70% Growth Over Prior Year Reiterates Full-Year 2019 Revenue Guidance SOUTH ORANGE, NJ, July 9, 2019 – Nephros, Inc. (OTCQB: NEPH), a commercial-stage company that…
Download PDF »SOUTH ORANGE, NJ, February 11, 2019 – Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, today announced the appointment…
LOS ANGELES, CA / ACCESSWIRE / March 7, 2019 / Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, today announced that…
SOUTH ORANGE, NJ, May 16, 2019 – Nephros, Inc. (OTCQB:NEPH) (the “Company”), a commercial stage company that develops and sells high performance water purification products to the medical device and…
Download PDF »Revenues up 80% over Q1 2018 Driven by Hospital Footprint Expansion Reiterates 2019 Guidance for Revenue Growth of 50% to 65% SOUTH ORANGE, NJ, May 8, 2019 – Nephros, Inc.…
Download PDF »SOUTH ORANGE, NJ, May 1, 2019 – Nephros, Inc. (OTCQB: NEPH), a commercial stage company that develops and sells high-performance water purification products to the medical device and commercial markets,…
SOUTH ORANGE, NJ, May 1, 2019 – Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, today announced that it…
SOUTH ORANGE, NJ, April 24, 2019 – Nephros, Inc. (OTCQB:NEPH), a commercial stage company that develops and sells high performance liquid purification filters for both medical device and commercial markets,…
Download PDF »SOUTH ORANGE, NJ, April 8, 2019 – Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device and commercial products company that develops and sells high performance water purification products, today…
SOUTH ORANGE, NJ, March 29, 2019 /PR Newswire-FirstCall/ – Nephros, Inc. (OTCQB:NEPH), a commercial stage company that develops and sells high performance liquid purification filters for both medical device and…
Nephros Reports 2018 Fourth Quarter and Full Year Financial Results and Provides Corporate Update Annual Product Revenues Up 54% SOUTH ORANGE, NJ, March 12, 2019 – Nephros, Inc. (OTCQB:NEPH), a…
SOUTH ORANGE, NJ, March 6, 2019 – Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, today announced that it…
LOS ANGELES, CA / ACCESSWIRE / March 7, 2019 / Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, today announced that…
SOUTH ORANGE, NJ, March 6, 2019 – Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, today announced that it…
SOUTH ORANGE, NJ, February 11, 2019 – Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, today announced the appointment…
Anticipates $5.6-5.7 Million Total Revenue; Product Revenue Growth Over 50% SOUTH ORANGE, NJ, January 9, 2018 – Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and…
Adds Growing Water Filtration Business in Food Service, Hospitality, and Industrial Markets Expands Water Filter Product Portfolio SOUTH ORANGE, NJ, January 2, 2019 – Nephros, Inc. (OTCQB: NEPH) (“Nephros”), a…
Presentation Scheduled for 9:30 AM PT on Tuesday, December 4th SOUTH ORANGE, NJ, Dec. 03, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nephros, Inc. (NEPH) (“Nephros”), a commercial stage medical…
Quarterly Product Revenue Up 96% Year-over-Year; Total Revenue Up 88% SOUTH ORANGE, N.J., Nov. 08, 2018 - Nephros, Inc. (NEPH) (“Nephros”), a commercial stage medical device company that develops and…
SOUTH ORANGE, NJ, November 1, 2018 – Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, today announced that it…
Anticipates 102% Year-over-Year Product Revenue Growth; Reiterates $6 Million 2018 Revenue Target SOUTH ORANGE, NJ, Oct. 01, 2018 -- Nephros, Inc. (NEPH), a commercial stage medical device company that develops…
SOUTH ORANGE, NJ, September 6, 2018 – Specialty Renal Products, Inc. (SRP), a private medical device company focused on the development of products for patients with renal disease, including a…
Pioneering HemoCleanse CEO to Join Specialty Renal Products Board of Directors SOUTH ORANGE, NJ, August 14, 2018 – Specialty Renal Products, Inc. (SRP), a subsidiary of Nephros, Inc. (OTCQB:NEPH), a…
Seasoned Executive Adds Significant Operational and M&A Expertise SOUTH ORANGE, NJ, August 13, 2018 -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high…
Total Revenue Up 59% Year-over-Year Company Plans Uplist to National Stock Exchange Conference Call Scheduled Today, August 8, at 4:30PM EDT SOUTH ORANGE, NJ, August 8, 2018 – Nephros, Inc. (OTCQB:…
Call scheduled for Wednesday, August 8th at 4:30 PM EDT August 3, 2018 – Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance…
Anticipates 57% Year-over-Year Revenue Growth; Establishes Specialty Renal Products Subsidiary SOUTH ORANGE, NJ, July 9, 2018 /PR Newswire-FirstCall/ – Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that…
Nephros to Present at 8th Annual LD Micro Invitational SOUTH ORANGE, NJ, June 4, 2018 /PR Newswire-FirstCall/ – Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells…
TRENTON, N.J. (May 10, 2018) – With support from the New Jersey Economic Development Authority (EDA), medical device maker Nephros, Inc. has developed and commercialized water-filtration systems designed to decrease…
Nephros Reports First Quarter 2018 Financial Results Quarterly Product Revenue Up 39% Year-over-Year; Reiterates Full-Year Revenue Guidance of $6 Million SOUTH ORANGE, NJ, May 9, 2018 /PR Newswire-FirstCall/ -- Nephros,…
Anticipates 39% Year-over-Year Product Revenue Growth; Reiterates $6 Million 2018 Revenue Target SOUTH ORANGE, NJ, April 16, 2018 /PR Newswire-FirstCall/ – Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device…
SOUTH ORANGE, NJ, April 11, 2018 /PR Newswire-FirstCall/ – Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line…
Nephros Reports 2017 Fourth Quarter and Full Year Financial Results and Provides Corporate Update Annual Revenues Up 65% and Cash Flow from Operations Approaches Breakeven SOUTH ORANGE, NJ, February 26,…
Nephros to Present at NobleCon14 SOUTH ORANGE, NJ, January 23, 2018 /PR Newswire-FirstCall/ - Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid…
Nephros Announces Preliminary Financial Results for Fourth Quarter 2017 Anticipates Over 80% Year-over-Year Product Revenue Growth for the Quarter SOUTH ORANGE, NJ, January 4, 2018 /PR Newswire-FirstCall/ – Nephros, Inc.…
Nephros Receives $1.8 Million in Cash from Sale of Tax Credits SOUTH ORANGE, NJ, December 13, 2017 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB: NEPH) a commercial stage medical device company that…
Nephros CFO to Present at the 10th Annual LD Micro Main Event LOS ANGELES, CA / ACCESSWIRE / December 4, 2017 / Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company…
Nephros Reports Third Quarter 2017 Financial Results Quarterly Revenue Up 93% Year-over-Year RIVER EDGE, NJ, November 9, 2017 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB: NEPH) (the “Company”), a commercial stage…
Nephros Announces Approval of $1.9 Million in NJEDA NOL Program Tax Credits Non-Dilutive Net Proceeds of Over $1.75 Million Expected in Late Q4 2017 RIVER EDGE, NJ, November 6, 2017…
Nephros Provides Corporate Update and Announces Preliminary Third Quarter 2017 Revenue Anticipates Over 90% Year-over-Year Revenue Growth in the Third Quarter and Cash Flow Breakeven around Year-End RIVER EDGE, NJ,…
Dear Friends and Shareholders, This is an exciting time for Nephros. Demand for our products is increasing, revenue and growth rates are expanding, and we anticipate continued progress. At the…
Nephros Reports Second Quarter Financial Results and Receives NJEDA Approval for Approximately $1.5 million in Funding from Sale of Tax Credits Revenue Increases 69% Year-over-Year RIVER EDGE, NJ, August 8,…
Nephros to Present at Marcum 2017 MicroCap Conference Presentation on Thursday June 15, 2017 at 4:00pm ET RIVER EDGE, NJ, June 9, 2017 -- Nephros, Inc. (OTCQB:NEPH) (the “Company”), a…
Nephros Reports 2017 First Quarter Financial Results and Provides Corporate Update RIVER EDGE, NJ, May 9, 2017 /Marketwired/ -- Nephros, Inc. (OTCQB: NEPH) (the “Company”), a commercial stage medical device…
Nephros Announces Partnership with WorldWater & Solar Technologies RIVER EDGE, NJ, April 24, 2017 /Issuer Direct / Nephros, Inc. (OTCQB:NEPH), (the “Company”) a commercial stage medical device company that develops…
Nephros Reports 2016 Fourth Quarter and Full Year Financial Results and Provides Corporate Update Anticipates 100% Year Over Year Growth in Medical Device Filters; Anticipates Reaching Cash Flow Positive in…
Nephros Announces $1.2 Million Private Placement RIVER EDGE, NJ--(Marketwired - Mar 17, 2017) - Nephros, Inc. ( OTCQB : NEPH ) (the "Company"), a commercial stage medical device company that develops and sells high…
Nephros Receives FDA 510(k) Clearance of EndoPurTM Endotoxin 10” Filter Launch Expected in Second Quarter of 2017 RIVER EDGE, NJ, March 6, 2017 /MarketWired/ -- Nephros, Inc. (OTCQB:NEPH) (the “Company”),…
Nephros Announces Appointment of Andrew Astor as Chief Financial Officer Technology Industry Veteran Andrew Astor Hired to Support Growth and Business Momentum RIVER EDGE, NJ, February 14, 2017 /Market Wire/…
Nephros Provides Corporate Update and Fourth Quarter 2016 Revenue Guidance --Projects Positive Cash Flow by Mid 2017-- RIVER EDGE, NJ, January 24, 2017 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH) (the…
Nephros Receives FDA 510(k) Clearance of HydraGuardTM 10” UltraFilter Expands Hospital Infection Control Product Line RIVER EDGE, NJ, December 27, 2016 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH) (the “Company”), a…
Nephros Provides Corporate Update and Third Quarter 2016 Revenue Guidance RIVER EDGE, NJ, October 11, 2016 /Issuer Direct/ -- Nephros, Inc. (OTCQB:NEPH) (the “Company”), a commercial stage medical device company…
RIVER EDGE, NJ, August 29, 2016 /Issuer Direct -- Nephros, Inc. (OTCQB:NEPH) (the “Company”), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and…
RIVER EDGE, NJ, August 25, 2016 /Issuer Direct/ -- Nephros, Inc. (OTCQB:NEPH) (the “Company”), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and…
RIVER EDGE, NJ, August 08, 2016 -- Nephros, Inc. (OTCQB: NEPH), (the “Company”) a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an…
RIVER EDGE, NJ, June 9, 2016 /Issuer’s Direct/ -- Nephros, Inc. (OTCQB:NEPH) (the “Company”), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and…
RIVER EDGE, NJ, May 23 , 2016 /Issuer Direct / -- Nephros, Inc. (OTCQB:NEPH), (the “Company”) a commercial stage medical device company that develops and sells high performance liquid purification…
RIVER EDGE, NJ, May 11, 2016 -- Nephros, Inc. (OTCQB: NEPH), (the “Company”) a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an…
RIVER EDGE, NJ, April 21, 2016 /Issuer Direct / -- Nephros, Inc. (OTCQB:NEPH), (the “Company”) a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters…
RIVER EDGE, NJ, April 14, 2016-- Nephros, Inc. (OTCQB:NEPH), (the “Company”) a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution…
Reports 90% Annual Ultrafilter Product Sales Growth— --Pending FDA clearance, Aims to launch the S100 Point of Use microfilter in 2Q’16 and the EndoPurTM Endotoxin Filter Cartridge near the end…
Nephros Launches SSUmini and Provides S100 Update RIVER EDGE, NJ, March 16, 2016 /Businesswire/ -- Nephros, Inc. (OTCQB:NEPH) (the “Company”), a commercial stage medical device company that develops and sells…
RIVER EDGE, NJ, February 1, 2016 /Businesswire/ -- Nephros, Inc. (OTCQB:NEPH) (the “Company”), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an…
RIVER EDGE, NJ, January 18, 2016 /Businesswire / -- Nephros, Inc. (OTCQB:NEPH),(the “Company”) a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an…
RIVER EDGE, NJ, December 30, 2015 /Businesswire / -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line…
River Edge, NJ, December 21, 2015/Businesswire/ -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution…
River Edge, NJ, November 20, 2015 /Businesswire/ -- Nephros, Inc. (OTCQB: NEPH), acommercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution…
RIVER EDGE, NJ, November 18, 2015 /Businesswire/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution…
Nephros Reports 2015 Third Quarter Financial Results RIVER EDGE, NJ, November 10, 2015 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high…
RIVER EDGE, NJ, October 27, 2015 /Businesswire/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution…
RIVER EDGE, NJ, October 22, 2015 /Businesswire/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution…
RIVER EDGE, NJ, September 30, 2015 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line…
Download PDF »RIVER EDGE, NJ, September 29, 2015 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line…
RIVER EDGE, NJ, September 21, 2015 /Businesswire/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution…
Nephros Appoints Moshe Pinto to its Board of Directors RIVER EDGE, NJ, August 17, 2015 /Businesswire/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells…
RIVER EDGE, NJ, August 10, 2015 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line…
RIVER EDGE, N.J., July 27, 2015 – Nephros, Inc. (OTCBB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution…
RIVER EDGE, NJ, May 19, 2015 /Businesswire/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution…
RIVER EDGE, NJ, May 19, 2015 /Businesswire/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution…
RIVER EDGE, NJ, May 12, 2015 /Businesswire/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution…
RIVER EDGE, NJ, May 8, 2015 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line…
RIVER EDGE, NJ, May 6, 2015 /Businesswire/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution…
RIVER EDGE, N.J.--(BUSINESS WIRE) January 7, 2015 -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution…
RIVER EDGE, NJ, December 18, 2014 -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution…
RIVER EDGE, NJ, October 28, 2014 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line…
RIVER EDGE, NJ, September 3, 2014 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line…
RIVER EDGE, NJ, August 14, 2014 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line…
RIVER EDGE, NJ, June 30, 2014 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line…
RIVER EDGE, NJ, May 19, 2014 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line…
RIVER EDGE, NJ, May 14, 2014 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line…
RIVER EDGE, NJ, May 14, 2014 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line…
RIVER EDGE, NJ, May 13, 2014 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line…
RIVER EDGE, NJ, March 28, 2014 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line…
RIVER EDGE, NJ, March 24, 2014 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line…
RIVER EDGE, NJ, March 11, 2014 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and Mar Cor…
RIVER EDGE, NJ, March 11, 2014 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and a Hemodiafiltration…
Click Here to view External Links
RIVER EDGE, NJ, August 13, 2013 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTC Bulletin Board:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced…
RIVER EDGE, NJ, November 14, 2013 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTC Bulletin Board:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced…
RIVER EDGE, NJ, November 29, 2013 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTC Bulletin Board: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters,…
RIVER EDGE, NJ, May 23, 2013 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTC Bulletin Board:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced…
RIVER EDGE, NJ, May 8, 2013 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTC Bulletin Board:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced…
RIVER EDGE, NJ, March 4, 2013 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTC Bulletin Board:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced…
RIVER EDGE, NJ, February 4, 2013 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTC Bulletin Board:NEPH) and Chem-Aqua, Inc., a wholly owned water treatment subsidiary of NCH Corporation, announced today that the…
RIVER EDGE, NJ, February 4, 2013 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTC Bulletin Board:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, today…
RIVER EDGE, NJ, January 15, 2013 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTC Bulletin Board:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced…
RIVER EDGE, NJ – April 23, 2012 - Nephros, Inc. (OTC Bulletin Board: NEPH), a medical device company developing and marketing filtration products for therapeutic applications, infection control, and advanced…
RIVER EDGE, NJ, November 8, 2012 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTC Bulletin Board:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced…
RIVER EDGE, NJ, August 14, 2012 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTC Bulletin Board:NEPH), a global medical device company developing and marketing filtration products for therapeutic applications, infection control, and…
RIVER EDGE, NJ, July 24, 2012 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTC Bulletin Board:NEPH), a global medical device company developing and marketing filtration products for therapeutic applications, infection control, and…
RIVER EDGE, NJ, May 15, 2012 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTC Bulletin Board:NEPH), a global medical device company developing and marketing filtration products for therapeutic applications, infection control, and…
RIVER EDGE, NJ – April 23, 2012 - Nephros, Inc. (OTC Bulletin Board: NEPH), a medical device company developing and marketing filtration products for therapeutic applications, infection control, and water…
RIVER EDGE, NJ – March 14, 2012 - Nephros, Inc. (OTC Bulletin Board: NEPH), a medical device company developing and marketing filtration products for therapeutic applications, infection control, and water…
RIVER EDGE, NJ – February 10, 2012 - Nephros, Inc. (OTC Bulletin Board: NEPH), a medical device company developing and marketing filtration products for therapeutic applications, infection control, and water…
RIVER EDGE, N.J., January 17, 2012 /PRNewswire/ -- Nephros, Inc. (OTC Bulletin Board:NEPH.OB - News), a medical device company developing and marketing filtration products for therapeutic applications, infection control, and…